Lupus Trial, Recruiting NCT05698173 Sponsor: University Hospital, Bordeaux Condition: Lupus
Back to Lupus

Lupus Trial, Recruiting

NCT05698173
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are male or female
  • People aged between 18 and 60 years old
  • People who have been diagnosed with systemic lupus erythematosus (a type of autoimmune disease) according to recognised medical diagnostic guidelines
  • People who are covered by health insurance
  • People who are willing to take part and sign a consent form

Who may not be able to join:

  • Women who are pregnant or breastfeeding
  • People who are under 18 years old
  • People who are in custody or whose freedom has been restricted by a legal or government decision
  • People who are under a legal protection order or who are not able to give their own consent to participate

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Noemie GENSOUS, MD, University Hospital, Bordeaux

Phone: (0)5 56 79 58 28

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
8 September 2023
Est. completion
1 September 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Absolute numbers of naïve T lymphocytes

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov